Oligoasthenospermia. Unspecified abnormal finding in specimens from male genital organs
Conditions
Interventions
Intervention group: Use of subcutaneous FSH in treatment of idiopathic oligoasthenospermia every other day for 6 months with dosage of 150 mg and comparison of Spermogram factors, hormone profile and
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
Male
Age
20 Years to 45 Years
Inclusion criteria
Inclusion criteria: Patient has an infertility problem Patient is not under any other treatment or does not have any indication of surgery oligoasthenospermia Patient does not have any background anatomical problems in urogenital system Patient's spouse is absolutely healthy in terms of fertility and has no problems
Exclusion criteria
Exclusion criteria: Creation of any anatomical disorder like Varicocele in urogenital system during the research History of any previous medical intervention or previous surgery
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Spermogram. Timepoint: before and after treatment (6 months after medication use). Method of measurement: Laboratory sampling.;Test of DNA damage in sperm (DNA fragmentation index). Timepoint: before and after treatment (6 months after medication use). Method of measurement: Laboratory sampling. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohsen Seyedi
Mashhad University of Medical Sciences
Outcome results
None listed